Free Trial
NASDAQ:EUDA

EUDA Health Q4 2025 Earnings Report

EUDA Health logo
$15.57 +0.11 (+0.71%)
As of 03:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

EUDA Health EPS Results

Actual EPS
-$0.44
Consensus EPS
-$1.20
Beat/Miss
Beat by +$0.76
One Year Ago EPS
N/A

EUDA Health Revenue Results

Actual Revenue
$1.92 million
Expected Revenue
$3.90 million
Beat/Miss
Missed by -$1.98 million
YoY Revenue Growth
N/A

EUDA Health Announcement Details

Quarter
Q4 2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

EUDA Health's next earnings date is estimated for Tuesday, July 28, 2026, based on past reporting schedules.

Conference Call Resources

EUDA Health Earnings Headlines

$30 stock to buy before Starlink goes public (WATCH NOW!)
A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker.tc pixel
See More EUDA Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like EUDA Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on EUDA Health and other key companies, straight to your email.

About EUDA Health

EUDA Health (NASDAQ:EUDA), Inc. (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation. These in-office treatment systems are complemented by a secure digital health platform that enables telehealth consultations, remote patient monitoring and real-time data insights for clinicians, aiming to improve patient adherence and clinical outcomes.

The company distributes its devices and digital health services through a hybrid model of direct sales to healthcare practices and partnerships with established medical distributors. While its primary market is in the United States, EUDA Health has initiated market entry programs in select international regions and collaborates with clinical investigators to expand its evidence base.

Led by a management team with deep experience in medical device innovation, digital therapeutics and women’s health, EUDA Health continues to pursue regulatory clearances, strategic collaborations and product enhancements. Through ongoing research and development efforts, the company aims to broaden its therapeutic offerings and further integrate its digital platform capabilities within the continuum of care.

View EUDA Health Profile